Breaks Categories: News

ThursdayJan 08, 2026 9:20 am

NetworkNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Study Shows Nu.Q Vet Feline Test Accurately Detects Lymphoma in Cats

VolitionRx (NYSE American: VNRX), a multinational epigenetics company, announced results from a clinical study demonstrating high accuracy of its Nu.Q Vet Feline assay in detecting lymphoma in cats, the most common cancer in the species. At 100% specificity, meaning no false positives, the blood-based assay detected more than 80% of feline lymphomas, supporting development of what the company expects to be the world’s first simple and affordable liquid biopsy test for feline cancer. The company stated that feline cancer has historically been difficult to diagnose early, often requiring invasive biopsies or costly imaging after symptoms have progressed, and noted that…

Continue Reading

ThursdayJan 08, 2026 9:05 am

NetworkNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Expands IBM Collaboration to Deliver Enterprise AI at the Edge in New York and Philadelphia

Datavault AI (NASDAQ: DVLT), a leader in instant data monetization and enterprise digital twins, announced it will deliver enterprise-grade artificial intelligence performance at the edge in New York and Philadelphia through an expanded collaboration with IBM using the SanQtum AI platform operated by Available Infrastructure. The deployment will utilize IBM watsonx AI products running within SanQtum AI’s zero-trust, micro edge data center network to enable cybersecure data storage and compute, real-time data scoring, tokenization, credentialing, and ultra-low-latency processing across two of the most data-dense metropolitan regions in the United States, supporting enterprise AI workloads without reliance on public cloud infrastructure.…

Continue Reading

ThursdayJan 08, 2026 9:00 am

NetworkNewsBreaks – Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) Expands Ovarian Cancer Trial With MD Anderson and GSK

Lixte Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collaboration with The University of Texas MD Anderson Cancer Center and pharmaceutical manufacturer GSK on an ongoing clinical trial evaluating its proprietary compound LB-100 in combination with GSK’s Dostarlimab for the treatment of ovarian clear cell cancer. The trial, initiated in January 2024 and led by Amir Jazaeri, MD, at MD Anderson, has added a second site at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University under the direction of Emily M. Hinchcliff, MD, MPH, and is expected to double enrollment to 42 patients following completion of its…

Continue Reading

WednesdayJan 07, 2026 1:02 pm

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Secures National Electronic Monitoring Contract in Western Europe, Expanding DV Solutions to 10th Country

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-Government, IoT and cybersecurity sectors, today announced it has secured a new national electronic monitoring contract in a Western European country through a partnership with a leading local service provider, marking the expansion of its proprietary domestic violence monitoring solutions to a tenth country worldwide and further strengthening its European footprint. The multi-year framework agreement, with a minimum term of three years, will support multiple national public safety agencies and programs, including domestic violence monitoring, GPS offender tracking and home detention, with the project expected to launch in the…

Continue Reading

WednesdayJan 07, 2026 12:46 pm

NetworkNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) Collaborates With Rokid to Enable Gesture Control for AI and AR Glasses

Wearable Devices (NASDAQ: WLDS) announced a collaboration with Rokid, a global pioneer in human-computer interaction and augmented reality, to enable natural, fast, and consistent gesture control for AI and AR glasses using the company’s Mudra Link neural wristband. Under the collaboration, Mudra Link and Rokid Glasses are compatible and ready for each other, featuring out-of-the-box pairing, pre-mapped gestures, and a shared setup flow, with joint marketing and consumer bundle opportunities planned for an initial rollout in the second quarter of 2026. The companies are also demonstrating the combined experience at CES 2026, highlighting a touch-free, wrist-based control approach designed to reduce friction in everyday interactions with smart glasses. announced…

Continue Reading

WednesdayJan 07, 2026 12:33 pm

NetworkNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Collaborates With Riflessi to Deploy Immersive Retail Media Technologies 

Datavault AI (NASDAQ: DVLT) announced a collaboration with Riflessi, a premium Fifth Avenue retail destination in New York City, to deploy the company’s DVHOLO(TM) holographic display platform and ADIO(R) spatial audio technology beginning in February 2026. The collaboration is designed to enable luxury fashion and lifestyle brands to sponsor immersive holographic and spatial audio experiences within high-value physical retail environments, supporting brand storytelling, pre-sale initiatives, and measurable consumer engagement while generating new revenue opportunities through Datavault AI’s data experience, valuation, and monetization framework. To view the full press release, visit https://nnw.fm/vjNrY About Datavault AI Inc. Datavault AI (NASDAQ: DVLT) is leading the way in AI experience, valuation, and monetization of assets in…

Continue Reading

WednesdayJan 07, 2026 12:11 pm

NetworkNewsBreaks – Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) Announces $4.3 Million Registered Direct Offering Priced at Market 

Lixte Biotechnology Holdings (NASDAQ: LIXT) entered into definitive agreements in a registered direct offering with accredited investors for the purchase and sale of approximately $4.3 million of Common Stock and pre-funded and investor warrants at a price of $4.09 per Common Unit, priced at the market under Nasdaq rules. The offering comprised 1,051,342 Common Units or Pre-Funded Units, each consisting of one share of Common Stock or one Pre-Funded Warrant and one Common Warrant exercisable at $3.96 per share, with the Common Warrants exercisable immediately and expiring 60 months from issuance. Gross proceeds totaled approximately $4.3 million, with net proceeds allocated for general corporate purposes and working capital. Spartan Capital Securities…

Continue Reading

WednesdayJan 07, 2026 10:55 am

NetworkNewsBreaks – Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) Closes $8.0 Million Registered Direct Offering

Estrella Immunopharma (NASDAQ: ESLA, ESLAW) announced the closing of its previously announced registered direct offering with a single healthcare-focused institutional investor, generating aggregate gross proceeds of approximately $8.0 million. The offering included the issuance of 4,063,290 shares of common stock and 1,000,000 pre-funded warrants, together with a concurrent private placement of common warrants to purchase up to 7,594,935 additional shares, with net proceeds expected to be used for general corporate purposes and working capital as the company advances its CD19 and CD22-targeted ARTEMIS T-cell therapy programs, including lead candidate EB103. Aegis Capital Corp. acted as exclusive placement agent for the…

Continue Reading

WednesdayJan 07, 2026 9:35 am

NetworkNewsBreaks – BlockQuarry Corp. (OTC: BLQC) Reports Strong Market Response to BLQCBuster(TM) Preorders

BlockQuarry (OTC: BLQC) reported strong market interest following the opening of preorders for its BLQCBuster(TM) crypto mining platform, citing significant inbound engagement from institutional and enterprise-scale operators seeking American-manufactured, high-uptime mining hardware. The company indicated that early inquiries reflect demand for domestic solutions to mitigate supply chain risk and support large-scale infrastructure upgrades, and that it is advancing a strategic “First-Off-Line” program under which select clients will validate initial production units ahead of broader multi-megawatt deployments. The BLQCBuster(TM), engineered in New York and manufactured in Pennsylvania, features a modular 2U rack-mountable design, hot-swappable nodes, and patent-pending Dynamic Superbalancing technology intended…

Continue Reading

WednesdayJan 07, 2026 9:10 am

NetworkNewsBreaks – A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Authorizes Up to $20 Million Share Repurchase Program

A2Z Cust2Mate Solutions (NASDAQ: AZ) announced that its board of directors has approved a share repurchase program authorizing the company to repurchase up to $20 million of its outstanding common shares in the open market over a period of up to three months. The company stated that the repurchase program reflects its view that the current market price of its common shares does not fully reflect its underlying value and prospects and represents an appropriate use of financial resources to enhance shareholder value. Oppenheimer & Co. Inc. has been engaged as broker for the program, which may be executed through…

Continue Reading